X
19
Recordati, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IBUPROFEN LYSINE, with a corresponding application number 21903.
Regulatory Information RX
With a dosage strength EQ 20MG BASE/2ML (EQ 10MG BASE/ML)
Dosage Form Route INJECTABLE; INTRAVENOUS
Reference Listed Drug Yes
Approved since 2006-04-13
Therapeutic Equivalence (TE) Code AP